The top line beat expectations, but the headline surprise was already partly disclosed. T1 posted $250.1 million of quarterly revenue, above published estimates around $203 million, but the company had already previewed a $245 million–$255 million range on July 28. That makes the exact revenue number new, not the direction of the result.
| Metric | Q2 2026 | Q2 2025 | Expectation / comparison |
|---|---|---|---|
| Total net sales | $250.1M | $132.8M | ~$203M consensus |
| Gross profit | $49.1M | $32.8M | 19.6% gross margin |
| Operating loss from continuing operations | $(22.8)M | $(31.4)M | Improved year over year |
| Net loss attributable to common stockholders | $(44.5)M | $(32.8)M | EPS loss $(0.16) total |
| EPS from continuing operations | $(0.14) | $(0.21) | About $(0.08) consensus |
| Adjusted EBITDA | $10.7M | $0.7M | Positive versus prior preliminary loss outlook |
| Operating cash flow | $(103.0)M | $(11.4)M | Material deterioration |
| Capital expenditures | $(161.8)M | $(51.9)M | Heavy investment phase |
| Cash, equivalents and restricted cash | $156.4M | $46.7M | Only $79.1M unrestricted cash |
Revenue growth translated into positive adjusted EBITDA, but not into earnings. Sales nearly doubled year over year and gross profit rose to $49.1 million, while adjusted EBITDA reached $10.7 million versus $0.7 million a year earlier (Income Statement; Non-GAAP Reconciliation). That is the strongest part of the quarter. However, common-stockholder loss widened to $44.5 million because of discontinued-operation losses, preferred dividends, and other below-operating-line costs (Income Statement). The result therefore looks better operationally than the GAAP EPS headline, but it was not a clean earnings beat.
The cash-flow profile is the central offset to the operating improvement. T1 used $103.0 million in operating cash and another $161.8 million on property and equipment during the first half, funded partly by $175.7 million of convertible-note proceeds (Cash Flow statement). Unrestricted cash stood at just $79.1 million at June 30, while convertible notes rose to $329.0 million from $153.0 million at year-end (Balance Sheet). The company is still spending heavily before the G2_Austin expansion is fully financed, leaving financing execution—not just production growth—as the key unresolved issue.
The net scorecard is mixed rather than a straightforward beat. The revenue result exceeded consensus and adjusted EBITDA was encouraging, but EPS missed the published range of expectations, cash consumption accelerated sharply, and leverage increased. With the sales range already known before the filing, the release mostly confirms improving production economics while highlighting that the balance sheet remains the constraint.
Read the original 8-K on SEC EDGAR ↗